Reductions in neuronal and glial density characterize the dorsolateral prefrontal cortex in bipolar disorder

被引:436
作者
Rajkowska, G
Halaris, A
Selemon, LD
机构
[1] Univ Mississippi, Med Ctr, Dept Psychiat & Human Behav, Lab Quantitat Neuroanat, Jackson, MS 39216 USA
[2] Yale Univ, Sch Med, Neurobiol Sect, New Haven, CT 06510 USA
关键词
postmortem; schizophrenia; mood disorders; human; frontal carter; morphometry;
D O I
10.1016/S0006-3223(01)01080-0
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Background: Bipolar disorder (BPD) is a mental illness in which depression and mania typically alternate, and both phases can present with psychotic features. The symptomatology of BPD, therefore, resembles major depressive disorder (MDD) and schizophrenia (SCHZ), posing diagnostic dilemmas. Distinct alterations in cellular architecture of the dorsolateral prefrontal cortex distinguish SCHZ and MDD, whereas the cellular neuropathology of BPD has not been studied. Methods: Dorsolateral prefrontal area 9 was analyzed using a three-dimensional morphometric method in postmortem brains from 10 BPD patients anti II matched nonpsychiatric control subjects. Results: Area 9 in BPD was characterized by, reduced neuronal density in layer III (16%-22%) and reduced pyramidal cell density in layers III and V (17%-30%). A 19% reduction in glial density tt was found in sublayer IIIc coupled with enlargement and changes in shape of glial nuclei spanning multiple layers. Conclusions: The morphologic signature of BPD, i.e,, decreased neuronal and glial density in association with glial hypertrophy, is distinct from previously described elevations in neuronal density in SCHZ, instead resembling the reductions in cell density found in MDD. Thus, the neuropathologic distinctions between BPD and SCHZ al e indicative of separate mental illnesses, each with a unique morphologic disturbance of specific neural circuits. (C) 2001 Society of Biological Psychiatry.
引用
收藏
页码:741 / 752
页数:12
相关论文
共 53 条
  • [1] [Anonymous], 1978, Schedule for Affective Disorders and Schizophrenia-Change version
  • [2] SCHIZOPHRENIA AND AFFECTIVE-DISORDER - ARE THEY GENETICALLY LINKED
    BARON, M
    GRUEN, RS
    [J]. BRITISH JOURNAL OF PSYCHIATRY, 1991, 159 : 267 - 270
  • [3] BAXTER LR, 1989, ARCH GEN PSYCHIAT, V46, P243
  • [4] BENES FM, 1986, ARCH GEN PSYCHIAT, V43, P31
  • [5] IS THE MECHANISM OF PREFRONTAL HYPOFUNCTION IN DEPRESSION THE SAME AS IN SCHIZOPHRENIA - REGIONAL CEREBRAL BLOOD-FLOW DURING COGNITIVE ACTIVATION
    BERMAN, KF
    DORAN, AR
    PICKAR, D
    WEINBERGER, DR
    [J]. BRITISH JOURNAL OF PSYCHIATRY, 1993, 162 : 183 - 192
  • [6] FRONTAL-CORTEX AND BASAL GANGLIA METABOLIC RATES ASSESSED BY POSITRON EMISSION TOMOGRAPHY WITH [F-18] 2-DEOXYGLUCOSE IN AFFECTIVE-ILLNESS
    BUCHSBAUM, MS
    WU, J
    DELISI, LE
    HOLCOMB, H
    KESSLER, R
    JOHNSON, J
    KING, AC
    HAZLETT, E
    LANGSTON, K
    POST, RM
    [J]. JOURNAL OF AFFECTIVE DISORDERS, 1986, 10 (02) : 137 - 152
  • [7] The mood-stabilizing agents lithium and valproate robustly increase the levels of the neuroprotective protein bcl-2 in the CNS
    Chen, G
    Zeng, WZ
    Yuan, PX
    Huang, LD
    Jiang, YM
    Zhao, ZH
    Manji, HK
    [J]. JOURNAL OF NEUROCHEMISTRY, 1999, 72 (02) : 879 - 882
  • [8] Long term lithium treatment suppresses p53 and Bax expression but increases Bcl-2 expression - A prominent role in neuroprotection against excitotoxicity
    Chen, RW
    Chuang, DM
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (10) : 6039 - 6042
  • [9] From Kraepelin to Kretschmer leavened by Schneider - The transition from categories of psychosis to dimensions of variation intrinsic to homo sapiens
    Crow, TJ
    [J]. ARCHIVES OF GENERAL PSYCHIATRY, 1998, 55 (06) : 502 - 504
  • [10] DUPONT RM, 1995, ARCH GEN PSYCHIAT, V52, P747